Feasibility and effectiveness of afatinib for poor performance status patients with EGFR-mutation-positive non-small-cell lung cancer: a retrospective cohort study

被引：0
|
作者：
Chiao-En Wu
Ching-Fu Chang
Chen-Yang Huang
Cheng-Ta Yang
Chih-Hsi Scott Kuo
Ping-Chih Hsu
John Wen-Cheng Chang
机构：
[1] Chang Gung University College of Medicine,Department of Internal Medicine, Division of Hematology
[2] Chang Gung University College of Medicine,Oncology, Chang Gung Memorial Hospital at Linkou
来源：
BMC Cancer | / 21卷
关键词：
Lung cancer; Afatinib; EGFR; TKI; Performance status;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Combination of afatinib with cetuximab in patients with EGFR-mutant non-small-cell lung cancer resistant to EGFR inhibitors
    Gomes, Jessica Ribeiro
    Cruz, Marcelo Rocha S.
    [J]. ONCOTARGETS AND THERAPY, 2015, 8 : 1137 - 1142
  • [42] Customized Chemotherapy on the Basis of EGFR Mutation Status for Elderly Patients With Advanced Non-Small-Cell Lung Cancer
    Kunimasa, K.
    Katakami, N.
    Masago, K.
    Yoshioka, H.
    Tomii, K.
    Kaneda, T.
    Hirabayashi, M.
    Morizane, T.
    Fujita, S.
    Mio, T.
    [J]. EUROPEAN JOURNAL OF CANCER, 2011, 47 : S280 - S280
  • [43] AFATINIB IN EGFR MUTANT NON-SMALL-CELL LUNG CANCER PATIENTS WITH ACQUIRED RESISTANCE TO REVERSIBLE EGFR-TKIS
    Cappuzzo, Federico
    Tiseo, Marcello
    Chiari, Rita
    Landi, Lorenza
    Ricciardi, Serena
    Rossi, Elisa
    Galetta, Domenico
    Novello, Silvia
    Milella, Michele
    D'Incecco, Armida
    Haspinger, Eva Regina
    Cortinovis, Diego
    Santo, Antonio
    Banna, Giuseppe
    Facchi-Netti, Francesco
    Levra, Matteo Giaj
    Vari, Sabrina
    Crino, Lucio
    De Marinis, Filippo
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S610 - S610
  • [44] EGFR and KRAS mutation status in non-small-cell lung cancer occurring in HIV-infected patients
    Crequit, Perrine
    Ruppert, Anne-Marie
    Rozensztajn, Nathalie
    Gounant, Valerie
    Vieira, T.
    Poulot, Virginie
    Antoine, Martine
    Chouaid, Christos
    Wislez, Marie
    Cadranel, Jacques
    Lavole, Armelle
    [J]. LUNG CANCER, 2016, 96 : 74 - 77
  • [45] Clinicopathological features and EGFR gene mutation status in elderly patients with resected non-small-cell lung cancer
    Nishii, Teppei
    Yokose, Tomoyuki
    Miyagi, Yohei
    Daigo, Yataro
    Ito, Hiroyuki
    Isaka, Tetsuya
    Imai, Kentaro
    Murakami, Shuji
    Kondo, Tetsuro
    Saito, Haruhiro
    Oshita, Fumihiro
    Yamada, Kouzo
    Matsukuma, Shoichi
    Tsuboi, Masahiro
    Nakayama, Haruhiko
    Masuda, Munetaka
    [J]. BMC CANCER, 2014, 14
  • [46] A prospective biomarker study in afatinib-treated patients with EGFR-mutation positive non-small cell lung
    Iwama, Eiji
    Sakai, Kazuko
    Azuma, Koichi
    Nozaki, Kaname
    Harada, Daijiro
    Hotta, Katsuyuki
    Ohyanagi, Fumiyoshi
    Nakanishi, Yoichi
    Nishio, Kazuto
    Okamoto, Isamu
    [J]. ANNALS OF ONCOLOGY, 2015, 26 : 83 - 83
  • [47] Immunohistochemistry for EGFR Mutation Detection in Non-Small-Cell Lung Cancer
    Hitij, Nina Turnsek
    Kern, Izidor
    Sadikov, Aleksander
    Knez, Lea
    Stanic, Karmen
    Zwitter, Matjaz
    Cufer, Tanja
    [J]. CLINICAL LUNG CANCER, 2017, 18 (03) : E187 - E196
  • [48] Prognostic Factors in Japanese EGFR Mutation-Positive Non-Small-Cell Lung Cancer: A Real-World Single-Center Retrospective Cohort Study
    Takashima, Kenta
    Wakabayashi, Hiroki
    Murakami, Yu
    Saiki, Atsuhito
    Matsuzawa, Yasuo
    [J]. DRUGS-REAL WORLD OUTCOMES, 2024,
  • [49] EGFR mutation and resistance of non-small-cell lung cancer to gefitinib
    Kobayashi, S
    Boggon, TJ
    Dayaram, T
    Janne, PA
    Kocher, O
    Meyerson, M
    Johnson, BE
    Eck, MJ
    Tenen, DG
    Halmos, B
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (08): : 786 - 792
  • [50] Efficacy and Safety of Nivolumab in Patients with Advanced Non-small-cell Lung Cancer and Poor Performance Status
    Katsura, Hideyuki
    Suga, Yukio
    Araya, Tomoyuki
    Kita, Toshiyuki
    Yoneda, Taro
    Tanaka, Nobuyoshi
    Kawabata, Ayumi
    Ishita, Sotoki
    Mase, Hiroki
    [J]. JOURNAL OF CANCER, 2019, 10 (10): : 2139 - 2144
12345